Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1961 1
1962 4
1963 4
1964 10
1965 2
1966 5
1967 10
1968 11
1969 5
1970 2
1971 4
1972 2
1974 2
1978 1
1980 3
1981 1
1982 1
1983 5
1984 6
1985 4
1986 3
1987 5
1988 4
1989 5
1990 5
1991 5
1992 3
1993 5
1994 7
1995 11
1996 5
1997 4
1998 5
1999 8
2000 14
2001 9
2002 14
2003 11
2004 10
2005 16
2006 20
2007 25
2008 29
2009 37
2010 26
2011 26
2012 25
2013 34
2014 40
2015 45
2016 41
2017 51
2018 39
2019 48
2020 41
2021 70
2022 73
2023 53
2024 39
2025 42
2026 32

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

957 results

Results by year

Filters applied: . Clear all
Page 1
Risk Factors for the Development of Psoriasis.
Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Kamiya K, et al. Among authors: kishimoto m. Int J Mol Sci. 2019 Sep 5;20(18):4347. doi: 10.3390/ijms20184347. Int J Mol Sci. 2019. PMID: 31491865 Free PMC article. Review.
Clinical features of psoriatic arthritis.
Kishimoto M, Deshpande GA, Fukuoka K, Kawakami T, Ikegaya N, Kawashima S, Komagata Y, Kaname S. Kishimoto M, et al. Best Pract Res Clin Rheumatol. 2021 Jun;35(2):101670. doi: 10.1016/j.berh.2021.101670. Epub 2021 Mar 17. Best Pract Res Clin Rheumatol. 2021. PMID: 33744078 Review.
Novel Therapy.
Kishimoto M, Nash P. Kishimoto M, et al. Best Pract Res Clin Rheumatol. 2025 Dec;39(4):102103. doi: 10.1016/j.berh.2025.102103. Epub 2025 Sep 26. Best Pract Res Clin Rheumatol. 2025. PMID: 41006162 No abstract available.
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis.
McInnes IB, Anderson JK, Magrey M, Merola JF, Liu Y, Kishimoto M, Jeka S, Pacheco-Tena C, Wang X, Chen L, Zueger P, Liu J, Pangan AL, Behrens F. McInnes IB, et al. Among authors: kishimoto m. N Engl J Med. 2021 Apr 1;384(13):1227-1239. doi: 10.1056/NEJMoa2022516. N Engl J Med. 2021. PMID: 33789011 Free article. Clinical Trial.
The Assessment of SpondyloArthritis International Society (ASAS) Consensus-Based Expert Definition of Difficult-to-Manage, including Treatment-Refractory, Axial Spondyloarthritis.
Poddubnyy D, Navarro-Compán V, Torgutalp M, Arends S, Aydin SZ, Battista S, van den Bosch F, Bundy C, Cauli A, Davies J, Dougados M, Duruöz T, El-Zorkany B, Fong W, van Gaalen F, Garcia-Salinas R, Garrido Cumbrera M, Géher P, Gensler L, Grazio S, Huang F, Kishimoto M, Landewé R, Leung YY, Machado PM, Marzo-Ortega H, Meghnathi B, Molto A, Nikiphorou E, Ramiro S, Rudwaleit M, Saad CGS, Sepriano A, Wei J, Baraliakos X, van der Heijde D; ASAS. Poddubnyy D, et al. Among authors: kishimoto m. Ann Rheum Dis. 2025 Apr;84(4):538-546. doi: 10.1016/j.ard.2025.01.035. Epub 2025 Feb 14. Ann Rheum Dis. 2025. PMID: 39955166 Free article. Review.
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial.
van der Heijde D, Song IH, Pangan AL, Deodhar A, van den Bosch F, Maksymowych WP, Kim TH, Kishimoto M, Everding A, Sui Y, Wang X, Chu AD, Sieper J. van der Heijde D, et al. Among authors: kishimoto m. Lancet. 2019 Dec 7;394(10214):2108-2117. doi: 10.1016/S0140-6736(19)32534-6. Epub 2019 Nov 12. Lancet. 2019. PMID: 31732180 Clinical Trial.
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb Study.
Baraliakos X, Østergaard M, Poddubnyy D, van der Heijde D, Deodhar A, Machado PM, Navarro-Compán V, Hermann KGA, Kishimoto M, Lee EY, Gensler LS, Kiltz U, Eigenmann MF, Pertel P, Readie A, Richards HB, Porter B, Braun J. Baraliakos X, et al. Among authors: kishimoto m. Arthritis Rheumatol. 2024 Aug;76(8):1278-1287. doi: 10.1002/art.42852. Epub 2024 Apr 30. Arthritis Rheumatol. 2024. PMID: 38556921 Clinical Trial.
The APLAR Recommendations for the Management of Psoriatic Arthritis.
Leung YY, Bird P, Haroon M, Kishimoto M, Shin K, Mathew AJ, Reyes H, Chau J, Neuen D, Chiowchanwisawakit P, Ridha AA, Xu C, Taylor W, Yahya F, So H, Fukui S, Van Hung N, Soroosh SG, Wahono CS, Pok LSL, Gonzales JR, Yeo YW, Dandeniya C, Morita A, Rahman PA, Basim S, Deshapriya K, Satti E, Phong ND, Kim MJ, Jha A, Cackamvalli PM, Rafique A, Islam MN, Tam LS. Leung YY, et al. Among authors: kishimoto m. Int J Rheum Dis. 2025 Aug;28(8):e70372. doi: 10.1111/1756-185x.70372. Int J Rheum Dis. 2025. PMID: 40725984
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Deodhar A, Van den Bosch F, Poddubnyy D, Maksymowych WP, van der Heijde D, Kim TH, Kishimoto M, Blanco R, Duan Y, Li Y, Pangan AL, Wung P, Song IH. Deodhar A, et al. Among authors: kishimoto m. Lancet. 2022 Jul 30;400(10349):369-379. doi: 10.1016/S0140-6736(22)01212-0. Lancet. 2022. PMID: 35908570 Clinical Trial.
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults.
Winter E, Dekkers O, Andreasen C, D'Angelo S, Appelman-Dijkstra N, Appenzeller S, Assmann G, Bubbear J, Bulaicon O, Chapurlat R, Choida V, Clunie GPR, Daoussis D, Diekhoff T, Flendrie M, Fogel O, Ghossan R, Girschick H, van Haalen F, Hamdy N, Hauser B, Hedrich C, Helliwell P, Hermann KG, Insalaco A, Jurik AG, Kishimoto M, Lems W, Miettunen P, Muche B, Cañete AN, Palmou-Fontana N, Smit F, Teh J, Verroken C, de Vlam K, Wendling D, Zhou W, Zmierczak HG, Leerling A. Winter E, et al. Among authors: kishimoto m. Ann Rheum Dis. 2025 Feb;84(2):169-187. doi: 10.1136/ard-2024-226446. Epub 2025 Jan 2. Ann Rheum Dis. 2025. PMID: 39919892 Free article.
957 results